Skip to main content

STIFEL FINANCIAL CORP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO

Position in REGN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$37,787,502
-$1,207,366 QoQ
Shares Held
48,907
-3.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.75302103993293.ToString("F0")% Shared 0.10223485390639378.ToString("F0")% None 3.1447441061606725.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $431,497,751 across 103 Biotechnology names. REGN ranks #3 (8.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
48,907 $37,787,502

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $37,787,502 48,907
2025-12-31 $38,994,868 50,520
2025-09-30 $25,551,232 45,443
2025-06-30 $19,770,975 37,659
2025-03-31 $24,179,383 38,124
2024-12-31 $27,129,799 38,086
2024-09-30 $50,717,071 48,245
2024-06-30 $47,269,019 44,974
2024-03-31 $43,224,461 44,909
2023-12-31 $36,606,246 41,679
2023-09-30 $25,536,446 31,030
2023-06-30 $19,864,036 27,645
2023-03-31 $18,952,637 23,066
2022-12-31 $17,385,741 24,097
2022-09-30 $17,298,901 25,112
2022-06-30 $24,386,475 41,254
2022-03-31 $31,239,625 44,729
2021-12-31 $27,378,284 43,353
2021-09-30 $27,302,087 45,114
2021-06-30 $24,739,408 44,293
2021-03-31 $13,145,720 27,784
2020-12-31 $14,308,267 29,617
2020-09-30 $22,399,595 40,015
2020-06-30 $23,663,149 37,943
2020-03-31 $9,239,420 18,922